BiotechCorp Annual Report 2007 - Malaysian Biotechnology ...

More documents

Recommendations

Info

40 The Statement o n C o r p o r a t e Governance
The Statement on Corporate Governance Corporate Governance Realising the importance of good corporate governance standards, notwithstanding the fact that it is not a listed company, the Board of Directors of BiotechCorp is commited to ensuring that the highest standard of corporate governance is adhered and complied with. Towards this end, the Board is guided by the Principles and Best Practices set out in the Malaysian Code of Corporate Governance (Revised 2007) in discharging the responsibilities and implementation of transparency and corporate accountability. 1. Board of Directors Composition of Board The Board of Directors of the Company comprise10 members made up of the following: - A non executive member appointed by the Prime Minister of Malaysia to serve as Chairman. - A Managing Director who will also serve as the Chief Executive Officer. - At least 5 non-executive members representating the Government of Malaysia. - At least 2 non-executive members representating the private corporate sector. - At least 1 non-executive member representating the research and development sector. Board Meetings The Board meets at least once in every quarter with additional meetings convened as and when required. During the financial year ended 31 December 2007, the Company convened a total of four meetings and the respective Director’s attendance is as follows: No. Name No. Of Meetings Attended 1 YBhg Tan Sri Datuk Dr Ahmad Zaharudin bin Idrus 3 2 YBhg Dato’ Iskandar Mizal bin Mahmood 4 3 YBhg Tan Sri Datuk Dr Haji Mohamed Ismail bin Merican 4 4 YBhg Dato’ Puteh Rukiah binti Abd Majid 4 5 YBhg Dato’ Abdul Hanan bin Alang Endut 3 6 YBhg Dato’ Sofian bin Mohd Salleh 1 7 Puan Zaiton binti Jamaluddin 3 8 Cik Nelleita binti Omar 4 9 Mr David Ho Sue San 3 10 Prof Dr Mary Jane Cardosa 3 During the financial year ended 31 December 2006, the Company convened a total of five meetings and the respective Director’s attendance is as follows:- No. Name No. Of Meetings Attended 1 YBhg Tan Sri Datuk Dr Ahmad Zaharudin bin Idrus 5 2 YBhg Dato’ Iskandar Mizal bin Mahmood 5 3 YBhg Tan Sri Datuk Dr Haji Mohamed Ismail bin Merican 3 4 YBhg Dato’ Abdul Rahim bin Mokti 3 5 YBhg Dato’ Abdul Hanan bin Alang Endut 2 6 YBhg Dato’ Sofian bin Mohd Salleh 3 7 Encik Alihan Haji A. Hamid 3 8 Puan Zaiton binti Jamaluddin 4 9 Cik Nelleita binti Omar 5 10 Mr David Ho Sue San 3 11 Prof Dr Mary Jane Cardosa 4 41
Page 1 and 2: BI TECH BEGINS BiotechCorp Annual R
Page 3 and 4: Industry Overview Facts & Figures 3
Page 5 and 6: Facts & Figures Malaysia’s compet
Page 7 and 8: The National Biotechnology Policy T
Page 9 and 10: Wealth Creation and Societal Wellbe
Page 11 and 12: Chairman’s Message YBhg Tan Sri D
Page 13 and 14: Number of BioNexus Companies by Sta
Page 15 and 16: Corporate Information • Registere
Page 17 and 18: 3. YBhg Tan Sri Datuk Dr Haji Moham
Page 19 and 20: 7. Puan Zaiton Jamaluddin Puan Zait
Page 22 and 23: 20 CEO's Office Monitoring & Compli
Page 24 and 25: 22 Biotechnology Begins
Page 26 and 27: 24 BiotechCorp also acts as a one-s
Page 28 and 29: 26 2005 • Launch of the National
Page 30 and 31: 28 Overview of Achievements
Page 32 and 33: 30 30 List of BioNexus Companies as
Page 34 and 35: 32 Mentoring Programmes BiotechCorp
Page 36 and 37: 34 Acquisition of new technology pl
Page 38 and 39: 36 Moving Forward
Page 40 and 41: 38 Potential Technology Platforms f
Page 44 and 45: 42 During the financial year ended
Page 46 and 47: 44 Membership composition of the si
Page 48 and 49: 46 (v) CWG on Funding Support Chair
Page 50 and 51: 48 Organisation and Management Stru
Page 52 and 53: 50 The Financial Statements
Page 54 and 55: 52 Malaysian Biotechnology Corporat
Page 56 and 57: 54 (Company No.691431-D) iii) which
Page 64 and 65: 62 (Company No.691431-D) Cash flow
Page 66 and 67: 64 (Company No.691431-D) 1. Signifi
Page 68 and 69: 66 (Company No.691431-D) 1. Signifi
Page 70 and 71: 68 (Company No.691431-D) 2. Propert
Page 72 and 73: 70 (Company No.691431-D) 6. Other p
Page 74 and 75: 72 (Company No.691431-D) 9. Deferre
Page 76 and 77: 74 13. Tax expense Reconcilation of
Page 78: 76 (Company No.691431-D) 16. Financ

BiotechCorp Annual Report 2007 - Malaysian Biotechnology ...

Create successful ePaper yourself

Delete template?

Save as template?